| Cognate memory CD4+ T cells generated with dendritic cell priming influence the expansion, trafficking, and differentiation of secondary CD8+ T cells and enhance tumor control ML Hwang, JR Lukens, TNJ Bullock The Journal of Immunology 179 (9), 5829-5838, 2007 | 735 | 2007 |
| Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma PJ Siska, KE Beckermann, FM Mason, G Andrejeva, AR Greenplate, ... JCI insight 2 (12), 2017 | 314 | 2017 |
| Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional … DW Mullins, SL Sheasley, RM Ream, TNJ Bullock, YX Fu, VH Engelhard The Journal of experimental medicine 198 (7), 1023-1034, 2003 | 282 | 2003 |
| Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells TNJ Bullock, H Yagita The Journal of Immunology 174 (2), 710-717, 2005 | 231 | 2005 |
| Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy TA Colella, TNJ Bullock, LB Russell, DW Mullins, WW Overwijk, ... The Journal of experimental medicine 191 (7), 1221-1232, 2000 | 203 | 2000 |
| PD-L1 expression and intratumoral heterogeneity across breast cancer subtypes and stages: an assessment of 245 primary and 40 metastatic tumors EA Dill, AA Gru, KA Atkins, LA Friedman, ME Moore, TN Bullock, JV Cross, ... The American journal of surgical pathology 41 (3), 334-342, 2017 | 174 | 2017 |
| Antigens derived from melanocyte differentiation proteins: Self‐tolerance, autoimmunity, and use for cancer immunotherapy VH Engelhard, TNJ Bullock, TA Colella, SL Sheasley, DW Mullins Immunological reviews 188 (1), 136-146, 2002 | 164 | 2002 |
| Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells TNJ Bullock, DW Mullins, VH Engelhard The Journal of Immunology 170 (4), 1822-1829, 2003 | 143 | 2003 |
| PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: correlation with tumor-infiltrating immune cells and clinical outcome JM Obeid, G Erdag, ME Smolkin, DH Deacon, JW Patterson, L Chen, ... Oncoimmunology 5 (11), e1235107, 2016 | 132 | 2016 |
| Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8+ T cells DJ Roberts, NA Franklin, LM Kingeter, H Yagita, AL Tutt, MJ Glennie, ... Journal of immunotherapy 33 (8), 769-779, 2010 | 126 | 2010 |
| Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets JD Lippolis, FM White, JA Marto, CJ Luckey, TNJ Bullock, J Shabanowitz, ... The Journal of Immunology 169 (9), 5089-5097, 2002 | 125 | 2002 |
| The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice TNJ Bullock, TA Colella, VH Engelhard The Journal of Immunology 164 (5), 2354-2361, 2000 | 124 | 2000 |
| Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. TN Bullock, LC Eisenlohr The Journal of experimental medicine 184 (4), 1319-1329, 1996 | 124 | 1996 |
| Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells LF Gemta, PJ Siska, ME Nelson, X Gao, X Liu, JW Locasale, H Yagita, ... Science Immunology 4 (31), eaap9520, 2019 | 116 | 2019 |
| Manipulation of avidity to improve effectiveness of adoptively transferred CD8+ T cells for melanoma immunotherapy in human MHC class I-transgenic mice TNJ Bullock, DW Mullins, TA Colella, VH Engelhard The Journal of Immunology 167 (10), 5824-5831, 2001 | 97 | 2001 |
| Metabolic influences that regulate dendritic cell function in tumors H Dong, TNJ Bullock Frontiers in immunology 5, 24, 2014 | 95 | 2014 |
| Focused ultrasound immunotherapy for central nervous system pathologies: challenges and opportunities CT Curley, ND Sheybani, TN Bullock, RJ Price Theranostics 7 (15), 3608, 2017 | 90 | 2017 |
| CD47 blockade as an adjuvant immunotherapy for resectable pancreatic cancer AD Michaels, TE Newhook, SJ Adair, S Morioka, BJ Goudreau, S Nagdas, ... Clinical Cancer Research 24 (6), 1415-1425, 2018 | 86 | 2018 |
| IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1 EA Dill, PM Dillon, TN Bullock, AM Mills Modern Pathology 31 (10), 1513-1522, 2018 | 80 | 2018 |
| Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes KM Hargadon, CC Brinkman, SL Sheasley-O’Neill, LA Nichols, ... The Journal of Immunology 177 (9), 6081-6090, 2006 | 74 | 2006 |
Victor H EngelhardProfessor of Microbiology, Immunology, and Cancer Biology, University of Virginia在 virginia.edu 的电子邮件经过验证
